Loading chat...
MO HB1158
Bill
Status
1/5/2012
Primary Sponsor
Sheila Solon
Click for details
AI Summary
-
Health benefit plans covering cancer chemotherapy cannot require higher copayments, deductibles, or coinsurance for orally administered anticancer medications than for intravenously administered or injected cancer medications.
-
Health carriers cannot achieve compliance by increasing copayments, deductibles, or coinsurance amounts for intravenously administered or injected cancer chemotherapy agents.
-
Health carriers may still require prior authorization and other appropriate utilization controls for chemotherapy coverage.
-
Exemptions apply to supplemental insurance policies including life care contracts, accident-only policies, specified disease policies, Medicare supplements, long-term care policies, and short-term major medical policies of six months or less.
-
Defines "health benefit plan" and "health carrier" using the same meanings from Missouri statute section 376.1350.
Legislative Description
Requires a health benefit plan to establish equal out-of-pocket requirements for an oral anticancer medication and an intravenously administered cancer medication
Last Action
Public Hearing Completed (H)
2/21/2012